Clinical trial
Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive…
NCT00469664 · Research Foundation for Mental Hygiene, Inc., Other · Unknown status
Key facts
| NCT number | NCT00469664 |
|---|---|
| Title | Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia |
| Official title | A Double Blind Placebo Controlled Study of Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia |
| Acronym | Guanfacine |
| Lead sponsor | Research Foundation for Mental Hygiene, Inc., Other |
| Collaborators | Bronx VA Medical Center U.S. Fed Icahn School of Medicine at Mount Sinai |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder, Cognitive Impairment |
| Intervention type | Drug |
| Interventions | Guanfacine/Tenex |
| Enrollment | 50 |
| Start date | Feb 1, 2000 |
| Primary completion | Aug 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | May 4, 2007 |
| Last update posted | May 21, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: